Charged particle therapy—optimization, challenges and future directions

[1]  V. Faria,et al.  SYSTEMATIC REVIEW OF LITERATURE , 2014 .

[2]  J. DeMarco,et al.  Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis. , 2013, International journal of radiation oncology, biology, physics.

[3]  Steven E Schild,et al.  Re: Proton vs intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. , 2013, Journal of the National Cancer Institute.

[4]  Myrna M. Khan,et al.  A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers , 2013, BMJ Open.

[5]  P. Gray,et al.  Proton Beam Radiation Therapy for Prostate Cancer—Is the Hype (and the Cost) Justified? , 2013, Current Urology Reports.

[6]  K. Hoffman,et al.  Radiation therapy modalities in prostate cancer. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  Zuofeng Li,et al.  Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression , 2013, Acta oncologica.

[8]  Zuofeng Li,et al.  Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials , 2013, Acta oncologica.

[9]  Y. Yoshioka,et al.  Radiotherapy targeting cancer stem cells: current views and future perspectives. , 2013, Anticancer research.

[10]  I. Vogelius,et al.  Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart. , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

[11]  R. Howell,et al.  Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient , 2013, Physics in medicine and biology.

[12]  S. Demaria,et al.  Combining radiotherapy and cancer immunotherapy: a paradigm shift. , 2013, Journal of the National Cancer Institute.

[13]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[14]  M. Durante,et al.  Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation , 2012, Journal of radiation research.

[15]  Y. Ohnishi,et al.  Long-term results of carbon ion radiation therapy for locally advanced or unfavorably located choroidal melanoma: usefulness of CT-based 2-port orthogonal therapy for reducing the incidence of neovascular glaucoma. , 2012, International journal of radiation oncology, biology, physics.

[16]  Søren M Bentzen,et al.  Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news? , 2011, International journal of radiation oncology, biology, physics.

[17]  L. Mishra,et al.  Hepatocellular carcinoma biology. , 2013, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[18]  H. Honda,et al.  Phase 1 trial of preoperative, short‐course carbon‐ion radiotherapy for patients with resectable pancreatic cancer , 2013, Cancer.

[19]  D. Louis,et al.  Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? , 2013, Nature Reviews Clinical Oncology.

[20]  Te Vuong,et al.  Past, present, and future of radiotherapy for the benefit of patients , 2013, Nature Reviews Clinical Oncology.

[21]  S. Korreman.  Motion in radiotherapy: photon therapy , 2012, Physics in medicine and biology.

[22]  D. Penson.  Re: Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. , 2012, The Journal of urology.

[23]  J. Petersen,et al.  Imaging hypoxia to improve radiotherapy outcome , 2012, Nature Reviews Clinical Oncology.

[24]  D. Jaffray.  Image-guided radiotherapy: from current concept to future perspectives , 2012, Nature Reviews Clinical Oncology.

[25]  M Scholz,et al.  Impact of enhancements in the local effect model (LEM) on the predicted RBE-weighted target dose distribution in carbon ion therapy , 2012, Physics in medicine and biology.

[26]  T. Yock,et al.  Risk of Second Cancers After Photon and Proton Radiotherapy: A Review of the Data , 2012, Health physics.

[27]  H. Paganetti.  Assessment of the Risk for Developing a Second Malignancy From Scattered and Secondary Radiation In Radiation Therapy , 2012, Health physics.

[28]  O. Yokosuka,et al.  Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  M. Durante.  Eighth Warren K. Sinclair Keynote Address: Heavy Ions in Therapy and Space: Benefits and Risks , 2012, Health physics.

[30]  Oliver Jäkel,et al.  Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data , 2012, Radiation oncology.

[31]  S. Oudard,et al.  New Insights into the Management of Renal Cell Cancer , 2012, Oncology.

[32]  Marco Durante,et al.  Motion mitigation in intensity modulated particle therapy by internal target volumes covering range changes. , 2012, Medical physics.

[33]  Zuofeng Li,et al.  Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. , 2012, International journal of radiation oncology, biology, physics.

[34]  D. Schardt,et al.  Out-of-field dose studies with an anthropomorphic phantom: comparison of X-rays and particle therapy treatments. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  H. Honda,et al.  Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk , 2012, Cancer.

[36]  J. Xue,et al.  Response of cancer stem-like cells and non-stem cancer cells to proton and γ-ray irradiation , 2012 .

[37]  Yugang Wang,et al.  Accumulation efficiency of cancer stem-like cells post γ-ray and proton irradiation , 2012 .

[38]  Marco Riboldi,et al.  Real-time tumour tracking in particle therapy: technological developments and future perspectives. , 2012, The Lancet. Oncology.

[39]  J. Kirkwood,et al.  Immunotherapy of cancer in 2012 , 2012, CA: a cancer journal for clinicians.

[40]  S. Laurberg,et al.  A 10‐year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[41]  D. Schardt,et al.  Out-of-field dose measurements in a water phantom using different radiotherapy modalities , 2012, Physics in medicine and biology.

[42]  K. P. Kim,et al.  Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study , 2012, The Lancet.

[43]  J. Slater,et al.  Radiation therapy modalities for prostate cancer. , 2012, JAMA.

[44]  Tadashi Kamada,et al.  A Review of Update Clinical Results of Carbon Ion Radiotherapy , 2012, Japanese journal of clinical oncology.

[45]  H. Stöcker,et al.  Relativistic protons for image-guided stereotactic radiosurgery , 2012 .

[46]  B. Yeap,et al.  Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  Zuofeng Li,et al.  Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy. , 2012, Oncology.

[48]  S. Kannan,et al.  Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma? , 2012, Journal of Neuro-Oncology.

[49]  M. Durante,et al.  Overcoming resistance of cancer stem cells. , 2012, The Lancet. Oncology.

[50]  S. McGovern,et al.  Progress in Radiotherapy for Pediatric Sarcomas , 2012, Current Oncology Reports.

[51]  Ronald C. Chen,et al.  Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. , 2012, JAMA.

[52]  R. Pötter,et al.  Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial , 2012, BMC Cancer.

[53]  Todd Pawlicki,et al.  An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[54]  H. Ishikawa,et al.  Carbon‐ion radiation therapy for prostate cancer , 2012, International journal of urology : official journal of the Japanese Urological Association.

[55]  Marco Durante,et al.  Particle therapy for noncancer diseases. , 2012, Medical physics.

[56]  J. Mechalakos,et al.  Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. , 2012, International journal of radiation oncology, biology, physics.

[57]  Dirk De Ruysscher,et al.  Charged particles in radiotherapy: a 5-year update of a systematic review. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[58]  K. Sugimura,et al.  A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[59]  T. Ogino.  Clinical evidence of particle beam therapy (proton) , 2012, International Journal of Clinical Oncology.

[60]  Jedd D. Wolchok,et al.  Immunologic correlates of the abscopal effect in a patient with melanoma. , 2012, The New England journal of medicine.

[61]  Sandrine A. Gaillard,et al.  Focusing of short-pulse high-intensity laser-accelerated proton beams , 2011, Nature Physics.

[62]  J. Debus,et al.  In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells , 2012, Radiation Oncology.

[63]  Jeffrey A. Brown,et al.  Cyberknife radiosurgery in treating trigeminal neuralgia , 2012, Journal of NeuroInterventional Surgery.

[64]  Hong Peng,et al.  Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.

[65]  Frank Verhaegen,et al.  Results of a Multicentric In Silico Clinical Trial (ROCOCO): Comparing Radiotherapy with Photons and Protons for Non-small Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[66]  U. Linz.  Ion Beam Therapy , 2012 .

[67]  A. Tefferi,et al.  Abscopal effect in a patient with melanoma. , 2012, New England Journal of Medicine.

[68]  Tzong-Shiue Yu,et al.  A restricted cell population propagates glioblastoma growth after chemotherapy , 2012 .

[69]  G. Freedman.  Hypofractionated Radiation Therapy in the Treatment of Early-Stage Breast Cancer , 2012, Current Oncology Reports.

[70]  David Robin,et al.  Superconducting toroidal combined-function magnet for a compact ion beam cancer therapy gantry , 2011 .

[71]  D. Hodgson.  Late effects in the era of modern therapy for Hodgkin lymphoma. , 2011, Hematology. American Society of Hematology. Education Program.

[72]  A. Niemierko,et al.  Proton stereotactic radiosurgery for the treatment of benign meningiomas. , 2011, International journal of radiation oncology, biology, physics.

[73]  Holly Ning,et al.  Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[74]  A. Niemierko,et al.  Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma , 2011, Cancer.

[75]  J. Cox,et al.  Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. , 2011, International journal of radiation oncology, biology, physics.

[76]  C Bert,et al.  Motion in radiotherapy: particle therapy , 2011, Physics in medicine and biology.

[77]  J. Slater,et al.  Partial breast irradiation delivered with proton beam: results of a phase II trial. , 2011, Clinical breast cancer.

[78]  Applications of particle accelerators in medicine. , 2011, Radiation protection dosimetry.

[79]  A. Niemierko,et al.  Modeling Intracranial Second Tumor Risk and Estimates of Clinical Toxicity with Various Radiation Therapy Techniques for Patients with Pituitary Adenoma , 2011, Technology in cancer research & treatment.

[80]  Marco Durante,et al.  Assessing the risk of second malignancies after modern radiotherapy , 2011, Nature Reviews Cancer.

[81]  John L. Meyer,et al.  The expanding roles of stereotactic body radiation therapy and oligofractionation: toward a new practice of radiotherapy. , 2011, Frontiers of radiation therapy and oncology.

[82]  R. Okayasu,et al.  Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. , 2011, Cancer research.

[83]  T. Teshima,et al.  Carbon ion irradiation suppresses metastatic potential of human non-small cell lung cancer A549 cells through the phosphatidylinositol-3-kinase/Akt signaling pathway. , 2011, Journal of radiation research.

[84]  Johannes A Langendijk,et al.  Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons. , 2011, Cancer treatment reviews.

[85]  H. Shih,et al.  Radiation therapy in the management of pituitary adenomas. , 2011, The Journal of clinical endocrinology and metabolism.

[86]  Qiang-Bing Li,et al.  Therapeutic techniques applied in the heavy-ion therapy at IMP , 2011 .

[87]  Johannes A Langendijk,et al.  The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature. , 2011, The oncologist.

[88]  Timothy L. Jackson,et al.  Radiation therapy for neovascular age-related macular degeneration , 2011, Clinical ophthalmology.

[89]  S Green,et al.  Particle therapy. , 2011, The British journal of radiology.

[90]  Uwe Oelfke,et al.  Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy. , 2011, International journal of radiation oncology, biology, physics.

[91]  R. Imai,et al.  Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery. , 2011, International journal of radiation oncology, biology, physics.

[92]  J. Debus,et al.  Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial , 2011, BMC Cancer.

[93]  H. Krum,et al.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial , 2010, The Lancet.

[94]  J. Debus,et al.  Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study , 2010, BMC Cancer.

[95]  J. Debus,et al.  Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study , 2010, BMC Cancer.

[96]  D. Schardt,et al.  Heavy ion radiotherapy during pregnancy. , 2010, Fertility and sterility.

[97]  A. Unterberg,et al.  glioblastoma: The CLEOPATRA Trial , 2022 .

[98]  Daniel Richter,et al.  Special report: Workshop on 4D-treatment planning in actively scanned particle therapy-Recommendations, technical challenges, and future research directions. , 2010, Medical physics.

[99]  A J Lomax,et al.  Proton range verification using a range probe: definition of concept and initial analysis , 2010, Physics in medicine and biology.

[100]  O. Yokosuka,et al.  Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[101]  H. Tsujii,et al.  Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials. , 2010, International journal of radiation oncology, biology, physics.

[102]  T. Nakano,et al.  Cost‐effectiveness of carbon ion radiation therapy for locally recurrent rectal cancer , 2010, Cancer science.

[103]  Y. Yonemitsu,et al.  Carbon‐ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma , 2010, Cancer.

[104]  Nzhde Agazaryan,et al.  Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma , 2010, BMC Cancer.

[105]  Radhe Mohan,et al.  Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study. , 2010, International journal of radiation oncology, biology, physics.

[106]  H. Igaki,et al.  Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme. , 2010, International journal of radiation oncology, biology, physics.

[107]  Andrzej Niemierko,et al.  Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer. , 2010, JAMA.

[108]  M. Moore,et al.  Advanced pancreatic carcinoma: current treatment and future challenges , 2010, Nature Reviews Clinical Oncology.

[109]  Kyounghwa Bae,et al.  Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[110]  Stine Korreman,et al.  The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[111]  Dieter Schardt,et al.  Heavy-ion tumor therapy: Physical and radiobiological benefits , 2010 .

[112]  James Ze Wang,et al.  Stereotactic body radiation therapy: a novel treatment modality , 2010, Nature Reviews Clinical Oncology.

[113]  Marco Durante,et al.  Charged particles in radiation oncology , 2010, Nature Reviews Clinical Oncology.

[114]  Manish K. Aghi,et al.  New advances that enable identification of glioblastoma recurrence , 2009, Nature Reviews Clinical Oncology.

[115]  T. Trikalinos,et al.  Systematic Review: Charged-Particle Radiation Therapy for Cancer , 2009, Annals of Internal Medicine.

[116]  J. Lau,et al.  Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation , 2009, Annals of Internal Medicine.

[117]  Simon Bouffler,et al.  Assessing cancer risks of low-dose radiation , 2009, Nature Reviews Cancer.

[118]  S. Demaria,et al.  Systemic effects of local radiotherapy. , 2009, The Lancet. Oncology.

[119]  D. de Ruysscher,et al.  Current Clinical Evidence for Proton Therapy , 2009, Cancer journal.

[120]  N. Fukumitsu,et al.  A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. , 2009, International journal of radiation oncology, biology, physics.

[121]  J. Geddes,et al.  What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.

[122]  J. Debus,et al.  Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base , 2009, Cancer.

[123]  B. Rudén,et al.  Hypofractionation in radiotherapy. An investigation of injured Swedish women, treated for cancer of the breast , 2009, Acta oncologica.

[124]  C. Lawton.  Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No , 2009 .

[125]  J. Lau,et al.  Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation , 2009 .

[126]  H. Tsujii,et al.  Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience. , 2008, International journal of radiation oncology, biology, physics.

[127]  A. Haimovitz-Friedman,et al.  Ceramide Biogenesis Is Required for Radiation-Induced Apoptosis in the Germ Line of C. elegans , 2008, Science.

[128]  J. Debus,et al.  Radiobiological Evaluation and Correlation with the Local Effect Model (lem) of Carbon Ion Radiation Therapy and Temozolomide in Glioblastoma Cell Lines , 2008 .

[129]  M. Krause,et al.  Exploring the role of cancer stem cells in radioresistance , 2008, Nature Reviews Cancer.

[130]  H. Tsujii,et al.  Clinical advantages of carbon-ion radiotherapy , 2008 .

[131]  Y. Yamada,et al.  High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. , 2008, International journal of radiation oncology, biology, physics.

[132]  Zuofeng Li,et al.  Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[133]  K. Ohtomo,et al.  Enhancement of Antitumor Radiation Efficacy and Consistent Induction of the Abscopal Effect in Mice by ECI301, an Active Variant of Macrophage Inflammatory Protein-1α , 2008, Clinical Cancer Research.

[134]  Sairos Safai,et al.  Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[135]  Andrew K. Lee.  Proton Therapy for Prostate Cancer , 2008 .

[136]  J. Petit,et al.  Proton radiosurgery in neurosurgery. , 2007, Neurosurgical focus.

[137]  D. Brenner,et al.  Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.

[138]  Buddy D. Ratner,et al.  A paradigm shift: biomaterials that heal , 2007 .

[139]  Michael Scholz,et al.  Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. , 2007, International journal of radiation oncology, biology, physics.

[140]  Brian Keith,et al.  Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.

[141]  Hirohiko Tsujii,et al.  Particle radiation therapy using proton and heavier ion beams. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[142]  Dirk De Ruysscher,et al.  Proton therapy in clinical practice: current clinical evidence. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[143]  H. Tsujii,et al.  Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. , 2007, International journal of radiation oncology, biology, physics.

[144]  V. Muriel.  Hypofractionation in radiotherapy. , 2007 .

[145]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[146]  E. Halperin.  Particle therapy and treatment of cancer. , 2006, The Lancet. Oncology.

[147]  T. Bortfeld.  IMRT: a review and preview , 2006, Physics in medicine and biology.

[148]  E. Hall,et al.  Intensity-modulated radiation therapy, protons, and the risk of second cancers. , 2006, International journal of radiation oncology, biology, physics.

[149]  Donna Brunero.  An institutional review , 2006 .

[150]  J. Sisterson.  Ion beam therapy in 2004 , 2005 .

[151]  Daniel W. Miller,et al.  Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. , 2005, JAMA.

[152]  J. Debus,et al.  Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques , 2005, Cancer.

[153]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[154]  Joseph M Kaminski,et al.  The controversial abscopal effect. , 2005, Cancer treatment reviews.

[155]  T. Teshima,et al.  Particle irradiation suppresses metastatic potential of cancer cells. , 2005, Cancer research.

[156]  J. Slater,et al.  High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. , 2004, Gastroenterology.

[157]  Frank B. Golley,et al.  Paradigm shift , 1989, Landscape Ecology.

[158]  R. Doll,et al.  Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[159]  C. Ogilvy,et al.  Dose-volume prediction of radiation-related complications after proton beam radiosurgery for cerebral arteriovenous malformations. , 2003, Journal of neurosurgery.

[160]  T. Teshima,et al.  Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. , 2003, Cancer research.

[161]  Zvi Fuks,et al.  Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.

[162]  T. McCulloch,et al.  Locoregional Treatment for Adult Soft Tissue Sarcomas of the Head and Neck: An Institutional Review , 2003, Cancer journal.

[163]  Harald Paganetti,et al.  Relative biological effectiveness (RBE) values for proton beam therapy. , 2002, International journal of radiation oncology, biology, physics.

[164]  S. Gabriel,et al.  Systematic Review of the Literature , 2021, Adherence to Antiretroviral Therapy among Perinatal Women in Guyana.

[165]  D. Brenner.  Toward optimal external-beam fractionation for prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[166]  G. Laramore.  The use of neutrons in cancer therapy: a historical perspective through the modern era. , 1997, Seminars in oncology.

[167]  Robert G. Moore,et al.  Initial clinical experience , 1997 .

[168]  J. Castro,et al.  Results of heavy ion radiotherapy , 1995, Radiation and environmental biophysics.

[169]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[170]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[171]  R D Adams,et al.  Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. , 1983, The New England journal of medicine.

[172]  K. Davis,et al.  Bragg peak proton beam therapy for arteriovenous malformation of the brain. , 1983, Clinical neurosurgery.

[173]  O. T. Lenning.  A Review and Preview. , 1976 .

[174]  T. Chou,et al.  Immunotherapy of cancer. , 1970, British medical journal.

[175]  Stanley Rogers,et al.  Review and Preview , 1965 .